CSC Announces Partnership with Carefx Corporation

CSCCSC (NYSE: CSC) announced a partnership with Carefx Corporation, a leading interoperability platform provider, to deliver a set of healthcare solutions designed to improve the quality and accessibility of information available to clinical staff at the point of care. With budgets under pressure and NHS Trusts tackling a number of UK Government policy initiatives, this collaboration comes at a critical time. By working in unison, CSC and Carefx can deliver innovative technology to help address these challenges and build efficiencies into the healthcare system.

The key component of the partnership will be the delivery of a Clinical Information Portal built on Carefx's Fusionfx platform. The portal will integrate NHS clinical and administrative applications residing either inside an NHS Trust or between multiple healthcare organisations, providing the ability to connect disparate systems and leverage and protect existing investments. By enabling Trusts to link existing systems, the portal not only extends the value of IT investments, it provides clinical and administrative staff with streamlined access to critical patient information from a single point of access, eliminating the need for data replication and new storage infrastructures.

"Partnering with key software developers like Carefx is critical in enabling us to provide the joined-up solutions that are so vital to the success of UK healthcare," says Andrew Spence, CSC's UK director of healthcare strategy. "Combining this innovative technology with our understanding of healthcare has the potential to deliver significant savings at a time when budgets are tighter than ever before."

"The Carefx partnership also demonstrates our ability to deliver solutions that ensure that the right information is delivered to the right people at the right time. Giving healthcare staff the fullest possible picture will improve continuity of care, patient safety and clinical productivity while reducing fragmentation to give the patient a better experience," Spence added.

Carefx Executive Vice President and General Manager for EMEA, Wayne Parslow, stated: "The aim for all healthcare organisations today is to improve the quality of patient care, while reducing the costs to the NHS of providing its services. Partnering with CSC strengthens our position in being able to do just this. By jointly deploying our Fusionfx platform we know that Trusts will be able to deliver secure, real-time access to relevant patient data, at that precise point in the care pathway. This is about meeting the needs of healthcare staff, the organisation and most importantly the patient."

By working collaboratively, CSC and Carefx can deliver solutions that not only meet the requirements of individual NHS Trusts, but can also support regional NHS partnerships and national interoperability programmes.

CSC's new solutions
The collaboration with Carefx on the Clinical Information Portal is one of several new solutions, services, and partnerships CSC is introducing to help healthcare organisations. The solutions have been tailored to help NHS Trusts tackle a number of UK Government policy initiatives, such as the QIPP (Quality, Innovation, Productivity and Prevention) agenda which identifies the importance of harnessing innovation and technology at key points in the patient journey. In addition to the clinical portal, two other solutions were launched in January, including the ePF (electronic patient folder) and Healthcare Self-Service Kiosks. Further solutions will be launched in 2010.

"To rise to these policy challenges - and free-up the resources required under the current stringent efficiency programme - Trusts are realising that they have to look at new ways of working, and that technology is key to that," comments Spence. "This is why we have developed solutions that focus on increasing efficiency, reducing costs and managing risk."

For further information regarding CSC healthcare solutions in the UK visit www.csc.com/cscalliance.

Related news articles:

  • CSC's Profile

About CSC
CSC is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions and Services, the Managed Services Sector and the North American Public Sector. CSC's advanced capabilities include system design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting. The company has been recognized as a leader in the industry, including being named by FORTUNE Magazine as one of the World's Most Admired Companies for Information Technology Services (2010). Headquartered in Falls Church, Va., CSC has approximately 92,000 employees and reported revenue of $16.0 billion for the 12 months ended Jan. 1, 2010. For more information, visit the company's Web site at www.csc.com.

About Carefx
Carefx supports healthcare organisations in achieving their vision of advancing the quality and safety of patient care delivery through its Fusionfx suite of interoperable workflow solutions. Fusionfx streamlines and simplifies clinical and business workflow and connects care providers to the information they need - where, when, and how they need it. By managing care transitions and information gaps between diverse systems, departments and facilities, Fusionfx delivers crucial patient information with speed, efficiency and logic. Carefx supports more than 700 hospitals, health systems, regional health information organizations (RHIOs) and health information exchanges (HIEs) across North America and Europe. Founded in 2002 and headquartered in Scottsdale, AZ, USA. Its EMEA headquarters are in Watford.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...